Humacyte Inc

NASDAQ:HUMA

2.28

-0.03 (-1.30%)

4:56:35 PM EDT: $2.23 -0.05 (-2.19%)

Market Cap (Intraday)	349.07M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.94 Million
Adjusted EPS	-$0.16

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Humacyte Inc Stock, NASDAQ:HUMA

2525 East North Carolina Highway 54, Durham, North Carolina 27713

United States of America

Phone: +1.919.313.9633

Number of Employees: 183

http://humacyte.com

Description

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.